The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure. This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill's work created better treatment options. Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.
The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.
Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill's research.
Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims. We are currently in FDA approved Clinical Trials with EPH-B4 which replaced the Veglin Trials.
John Ferruccio presents Chairman of the Medical Advisory Board, Dr. Parkash Gill, the generous donation of $200,000.00.
Mel Breshears presented the Foundation's Chairman of the Medical Advisory Committee, Dr. Parkash Gill, with the proceeds from the event, approximately $73,000.00!
Once again, we returned to the Moore-N-Moore Sporting Clays facility in the San Fernando Valley, CA, which witnessed a great turnout, generating approximately $32,000 for mesothelioma research.
On July 28th, the 2016 14th Annual District Council 16 Golf Invitational witnessed a huge turnout of over 140 golfers, who came together to support the cause while generating approximately $105k for mesothelioma research!
The June 2016 “Aim to Cure” event hosted by Foundation Board Member and Retired International Pipetrades Representative Jim Kellogg saw another great turnout of over 100 supporters.
We were overjoyed to hear from International Vice President of the Heat & Frost Insulators, Doug Gamble, and the Business Manager of Local 16 Heat & Frost Insulators, Mel Breshears, who decided to bring back the event that had become a staple of the Mesothelioma Research Foundation of America.
Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center has announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Phase I Clinical Trials and is available to qualifying mesothelioma patients. In the initial Phase I Trial EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options and to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting as Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs as Alimta, Cisplatin and Carboplatin.
Please use our FaceBook link to obtain your FREE copy of our eBook that teaches:
Ask us questions about your specific mesothelioma issues here: Ask Questions
In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:
There have been significant improvements creating new options for patients with Mesothelioma lung cancer. This video presents the new options for a patient to be aware of and consider. This news release video, created by Med Page Today, is about Oncology and Lung Cancer has been shared on YouTube by the Mesothelioma Research Foundation of America.
The Mesothelioma Research Foundation of America is the proud recipient of a grant from the John S. Lyons Memorial Foundation, charitable branch of the San Diego Building Trades Councel, to help support clinical studies of Dr. Parkash Gill's protein known as EPH B4 as a mesothelioma cancer treatment option.
For questions related to the foundation and to make contributions please contact:
(800) 909-Meso (6376)
3011 Townsgate Rd, Suite 450
Westlake Village, CA 91361
For more information and other questions contact:
©2017 Mesothelioma Research Foundation Of America